SlideShare a Scribd company logo
TIME IS OF THE ESSENCE IN DRUG DEVELOPMENT.
CONTACT THE QPS BUSINESS DEVELOPMENT TEAM TODAY!
CALL +1 512 350 2827 EMAIL infobd@qps.com
DMPK
A flexible approach to
QPS DMPK PROVIDES A DEDICATED
TEAM OF SENIOR SCIENTISTS TO HELP SELECT,
design and conduct the appropriate ADME studies
for your specific compounds and therapeutic targets.
Working with QPS DMPK is a collaborative and consultative
endeavor that also incorporates our operational effectiveness
and dedication to customer service.
Fargo, ND, USA
Dermal and Transdermal
Research Laboratory (DTRL)
Groningen and Leeuwarden,
The Netherlands
Bioanalysis (BA)
Clinical Research Services (CRS)
Translational Medicine (TLM)
Suzhou and Shanghai,
China
Bioanalysis (BA)
Clinical Research Services (CRS)
Miami, FL, USA
Clinical Research
Services (CRS)
Hyderabad, India
Bioanalysis (BA)
Clinical Research
Services (CRS)
Taipei, Taiwan
Bioanalysis (BA)
Clinical Research Services (CRS)
Toxicology (TOX)
Newark, DE, USA
Bioanalysis (BA)
Clinical Research Services (CRS)
DMPK
Translational Medicine (TLM)
Global Headquarters for
QPS Holdings LLC
Graz, Austria
Clinical Research Services (CRS)
DMPK
Histology Services
Neuropharmacology
Rare Disease
Rodent Biobank
Springfield, MO, USA
Clinical Research
Services (CRS)
Macro & Micro Autoradiography
One of QPS’ main services in DMPK is the combined mass
balance, biliary excretion, PK, and QWBA studies.
	
f Increased efficiency by using a single study protocol
	
f Better study oversight with an integrated study report
	
f Elimination of the possibility of radiolabel degrading over
an extended period of time between the two studies
	
f Metabolite profiling and identification can be done using
the samples from the same study
	
f Micro-autoradiography provides insight into sub-cellular
tissue distribution
Biotransformation
QPS biotransformation studies determine how a molecule
may be altered by the action of enzymes. These study
types include:
	
f In vitro metabolic stability in hepatic subcellular fractions
to determine intrinsic clearance
	
f In vitro comparison of metabolite formation in animal
and human hepatic preparations, using non-labeled and
radio-labeled test articles
	
f In vivo metabolite profiling, identification and
quantification using samples collected from animal PK,
mass balance excretion studies, and human AME studies
to satisfy Metabolites in Safety Testing (MIST)
Protein Binding
QPS protein binding studies determine the extent of
protein binding in various plasma species and tissues.
	
f Methods: equilibrium dialysis (RED, Harvard device, 96-
well HTD), ultrafiltration, and ultracentrifugation
	
f Discovery screening, in vitro protein binding for IND, and
ex vivo studies in clinical phases
	
f Experience in compounds with very high binding, stability
issues, or non-specific issues
Drug-Drug Interaction
QPS drug interaction studies determine the potential of
a substance to alter cytochrome P450 activity. Studies
conducted to assess inhibition and induction potential
to support discovery and development of new drug
candidates are:
	
f In vitro inhibition characterization in human liver
microsomes or hepatocytes to determine reversible or
time dependent IC50
	
f In vitro mechanistic characterization of reversible
inhibitory rate constants Ki
	
f Identification of the reversible mechanism of inhibition as
competitive, non-competitive or uncompetitive
	
f In vitro mechanistic characterization of time dependent
inhibition Kinact
and KI
	
f Identification of the mechanism of time dependent
inhibition as metabolite mediated via covalent
modification or due to tight binding effect of substrate
	
f In vitro characterization of CYP1A2, CYP2B6, and CYP3A4
induction potential in human hepatocytes based on
mRNA and/or CYP activity using isoform selective probe
substrates
QPS is a Global CRO with locations around the world
WWW.QPS.COM

More Related Content

What's hot

DerekLadBuhrCoverLetter2015
DerekLadBuhrCoverLetter2015DerekLadBuhrCoverLetter2015
DerekLadBuhrCoverLetter2015Derek Lad Buhr
 
Tsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidentialTsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidential
Drew Hertig, MBA, CLP
 
Tsrl fact sheet potent dna therapeutics may 2016
Tsrl fact sheet potent dna therapeutics may 2016Tsrl fact sheet potent dna therapeutics may 2016
Tsrl fact sheet potent dna therapeutics may 2016
Drew Hertig, MBA, CLP
 
Pharmaceuticals Dashboard 2021
Pharmaceuticals Dashboard 2021Pharmaceuticals Dashboard 2021
Pharmaceuticals Dashboard 2021
Obaid Ali / Roohi B. Obaid
 
Introduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelIntroduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator Model
Drew Hertig, MBA, CLP
 
TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016Drew Hertig, MBA, CLP
 
The Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White PaperThe Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White Paper
Covance
 
QPS IND Proof-of-Concept Flyer
QPS IND Proof-of-Concept FlyerQPS IND Proof-of-Concept Flyer
QPS IND Proof-of-Concept Flyer
QPS Holdings, LLC
 
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
bryonmain
 
Effective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar ProductsEffective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar Products
PAREXEL International
 
ctt-mediaKit_010411v1_spreads
ctt-mediaKit_010411v1_spreadsctt-mediaKit_010411v1_spreads
ctt-mediaKit_010411v1_spreadsTracy Critchfield
 
Working for Dedevan
Working for DedevanWorking for Dedevan
Working for Dedevan
aelbrechtgreet
 
Attention to Detail Drives APH Assay Quality
Attention to Detail Drives APH Assay QualityAttention to Detail Drives APH Assay Quality
Attention to Detail Drives APH Assay Quality
Covance
 
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_QualityChemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
Ajaz Hussain
 
Professional Services Snapshot Overview
Professional Services Snapshot OverviewProfessional Services Snapshot Overview
Professional Services Snapshot Overview
paulinekearse
 
Todd Lewis Resume
Todd Lewis ResumeTodd Lewis Resume
Todd Lewis ResumeTodd Lewis
 
Visioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA CollaborationVisioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA Collaboration
Ajaz Hussain
 
UC BRAID D4
UC BRAID D4UC BRAID D4
UC BRAID D4
CTSI at UCSF
 

What's hot (20)

How new drugs_are_developed_1_ (1)
How new drugs_are_developed_1_ (1)How new drugs_are_developed_1_ (1)
How new drugs_are_developed_1_ (1)
 
DerekLadBuhrCoverLetter2015
DerekLadBuhrCoverLetter2015DerekLadBuhrCoverLetter2015
DerekLadBuhrCoverLetter2015
 
Tsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidentialTsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidential
 
Tsrl fact sheet potent dna therapeutics may 2016
Tsrl fact sheet potent dna therapeutics may 2016Tsrl fact sheet potent dna therapeutics may 2016
Tsrl fact sheet potent dna therapeutics may 2016
 
Pharmaceuticals Dashboard 2021
Pharmaceuticals Dashboard 2021Pharmaceuticals Dashboard 2021
Pharmaceuticals Dashboard 2021
 
Introduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelIntroduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator Model
 
TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016
 
CV_AN
CV_ANCV_AN
CV_AN
 
The Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White PaperThe Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White Paper
 
QPS IND Proof-of-Concept Flyer
QPS IND Proof-of-Concept FlyerQPS IND Proof-of-Concept Flyer
QPS IND Proof-of-Concept Flyer
 
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
 
Effective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar ProductsEffective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar Products
 
ctt-mediaKit_010411v1_spreads
ctt-mediaKit_010411v1_spreadsctt-mediaKit_010411v1_spreads
ctt-mediaKit_010411v1_spreads
 
Working for Dedevan
Working for DedevanWorking for Dedevan
Working for Dedevan
 
Attention to Detail Drives APH Assay Quality
Attention to Detail Drives APH Assay QualityAttention to Detail Drives APH Assay Quality
Attention to Detail Drives APH Assay Quality
 
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_QualityChemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
 
Professional Services Snapshot Overview
Professional Services Snapshot OverviewProfessional Services Snapshot Overview
Professional Services Snapshot Overview
 
Todd Lewis Resume
Todd Lewis ResumeTodd Lewis Resume
Todd Lewis Resume
 
Visioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA CollaborationVisioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA Collaboration
 
UC BRAID D4
UC BRAID D4UC BRAID D4
UC BRAID D4
 

Similar to QPS DMPK

QPS Neuropharmacology
QPS NeuropharmacologyQPS Neuropharmacology
QPS Neuropharmacology
QPS Holdings, LLC
 
QPS Radiolabeled ADME Studies
QPS Radiolabeled ADME StudiesQPS Radiolabeled ADME Studies
QPS Radiolabeled ADME Studies
QPS Holdings, LLC
 
QPS Global Capabilities Presentation
QPS Global Capabilities PresentationQPS Global Capabilities Presentation
QPS Global Capabilities Presentation
Edwin van Vulpen
 
QPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large MoleculesQPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large Molecules
QPS Holdings, LLC
 
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptxPRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
DharaMehta45
 
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptxPRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
DharaMehta45
 
Hao Liu Resume 2017-02
Hao Liu Resume 2017-02Hao Liu Resume 2017-02
Hao Liu Resume 2017-02Hao Liu
 
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
Trustlife
 
DerekPoore 2015 CV
DerekPoore 2015 CVDerekPoore 2015 CV
DerekPoore 2015 CVDerek Poore
 
Deecher D Cv 3.5.09
Deecher D Cv 3.5.09Deecher D Cv 3.5.09
Deecher D Cv 3.5.09
guest20d1ac
 
QPS CSF Sampling
QPS CSF SamplingQPS CSF Sampling
QPS CSF Sampling
QPS Holdings, LLC
 
MDC Connects: Target discovery at AstraZeneca
MDC Connects: Target discovery at AstraZenecaMDC Connects: Target discovery at AstraZeneca
MDC Connects: Target discovery at AstraZeneca
Medicines Discovery Catapult
 
Ouellette, Michael_Resume 2016
Ouellette, Michael_Resume 2016Ouellette, Michael_Resume 2016
Ouellette, Michael_Resume 2016Mike Ouellette
 
biomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFbiomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFOuriel Faktor
 

Similar to QPS DMPK (20)

QPS Neuropharmacology
QPS NeuropharmacologyQPS Neuropharmacology
QPS Neuropharmacology
 
QPS Radiolabeled ADME Studies
QPS Radiolabeled ADME StudiesQPS Radiolabeled ADME Studies
QPS Radiolabeled ADME Studies
 
Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
 
Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
 
Drug Design:Discovery, Development and Delivery
Drug Design:Discovery, Development and DeliveryDrug Design:Discovery, Development and Delivery
Drug Design:Discovery, Development and Delivery
 
QPS Global Capabilities Presentation
QPS Global Capabilities PresentationQPS Global Capabilities Presentation
QPS Global Capabilities Presentation
 
QPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large MoleculesQPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large Molecules
 
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptxPRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
 
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptxPRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
 
Lisa_Grimm
Lisa_GrimmLisa_Grimm
Lisa_Grimm
 
Hao Liu Resume 2017-02
Hao Liu Resume 2017-02Hao Liu Resume 2017-02
Hao Liu Resume 2017-02
 
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
 
DerekPoore 2015 CV
DerekPoore 2015 CVDerekPoore 2015 CV
DerekPoore 2015 CV
 
Deecher D Cv 3.5.09
Deecher D Cv 3.5.09Deecher D Cv 3.5.09
Deecher D Cv 3.5.09
 
Lisa_Grimm
Lisa_GrimmLisa_Grimm
Lisa_Grimm
 
QPS CSF Sampling
QPS CSF SamplingQPS CSF Sampling
QPS CSF Sampling
 
MDC Connects: Target discovery at AstraZeneca
MDC Connects: Target discovery at AstraZenecaMDC Connects: Target discovery at AstraZeneca
MDC Connects: Target discovery at AstraZeneca
 
Ouellette, Michael_Resume 2016
Ouellette, Michael_Resume 2016Ouellette, Michael_Resume 2016
Ouellette, Michael_Resume 2016
 
biomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFbiomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDF
 
TFadra-Khan Resume
TFadra-Khan ResumeTFadra-Khan Resume
TFadra-Khan Resume
 

More from QPS Holdings, LLC

Defining a Full Service ADME Data Package
Defining a Full Service ADME Data Package Defining a Full Service ADME Data Package
Defining a Full Service ADME Data Package
QPS Holdings, LLC
 
QPS Bioanalysis General
QPS Bioanalysis General QPS Bioanalysis General
QPS Bioanalysis General
QPS Holdings, LLC
 
QPS Immunogenicity
QPS ImmunogenicityQPS Immunogenicity
QPS Immunogenicity
QPS Holdings, LLC
 
QPS Negative Pressure Room
QPS Negative Pressure RoomQPS Negative Pressure Room
QPS Negative Pressure Room
QPS Holdings, LLC
 
QPS Regulated Bioanalysis of Antibody Drug Conjugates
QPS Regulated Bioanalysis of Antibody Drug ConjugatesQPS Regulated Bioanalysis of Antibody Drug Conjugates
QPS Regulated Bioanalysis of Antibody Drug Conjugates
QPS Holdings, LLC
 
QPS Gene Therapy Milestones
QPS Gene Therapy MilestonesQPS Gene Therapy Milestones
QPS Gene Therapy Milestones
QPS Holdings, LLC
 
QPS Bioanalysis Milestones
QPS Bioanalysis MilestonesQPS Bioanalysis Milestones
QPS Bioanalysis Milestones
QPS Holdings, LLC
 
Overcoming Pediatric Trial Challenges
Overcoming Pediatric Trial ChallengesOvercoming Pediatric Trial Challenges
Overcoming Pediatric Trial Challenges
QPS Holdings, LLC
 
Biosimilar Dug Development
Biosimilar Dug DevelopmentBiosimilar Dug Development
Biosimilar Dug Development
QPS Holdings, LLC
 
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS Disorders
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS DisordersThree Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS Disorders
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS Disorders
QPS Holdings, LLC
 
RNAi Therapeutics
RNAi TherapeuticsRNAi Therapeutics
RNAi Therapeutics
QPS Holdings, LLC
 
Pharmacokinetic Studies in Patients
Pharmacokinetic Studies in PatientsPharmacokinetic Studies in Patients
Pharmacokinetic Studies in Patients
QPS Holdings, LLC
 
Seeking Drug Approval via the 505(b)(2) NDA Option
Seeking Drug Approval via the 505(b)(2) NDA OptionSeeking Drug Approval via the 505(b)(2) NDA Option
Seeking Drug Approval via the 505(b)(2) NDA Option
QPS Holdings, LLC
 
Transdermal Delivery Systems
Transdermal Delivery SystemsTransdermal Delivery Systems
Transdermal Delivery Systems
QPS Holdings, LLC
 
Selecting the Location of a Phase I Clinical Trial Site for EU Registration
Selecting the Location of a Phase I Clinical Trial Site for EU RegistrationSelecting the Location of a Phase I Clinical Trial Site for EU Registration
Selecting the Location of a Phase I Clinical Trial Site for EU Registration
QPS Holdings, LLC
 
ICP-MS for Elemental Analysis in Drug Development
ICP-MS for Elemental Analysis in Drug DevelopmentICP-MS for Elemental Analysis in Drug Development
ICP-MS for Elemental Analysis in Drug Development
QPS Holdings, LLC
 
Large Molecule Bioanalysis: LC-MS or ELISA? A Case Study
Large Molecule Bioanalysis: LC-MS or ELISA? A Case StudyLarge Molecule Bioanalysis: LC-MS or ELISA? A Case Study
Large Molecule Bioanalysis: LC-MS or ELISA? A Case Study
QPS Holdings, LLC
 
QPS Human Mass Balance Presentation
QPS Human Mass Balance PresentationQPS Human Mass Balance Presentation
QPS Human Mass Balance Presentation
QPS Holdings, LLC
 
QPS-NL Respiratory Capabilities Presentation
QPS-NL Respiratory Capabilities PresentationQPS-NL Respiratory Capabilities Presentation
QPS-NL Respiratory Capabilities Presentation
QPS Holdings, LLC
 
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...
QPS Holdings, LLC
 

More from QPS Holdings, LLC (20)

Defining a Full Service ADME Data Package
Defining a Full Service ADME Data Package Defining a Full Service ADME Data Package
Defining a Full Service ADME Data Package
 
QPS Bioanalysis General
QPS Bioanalysis General QPS Bioanalysis General
QPS Bioanalysis General
 
QPS Immunogenicity
QPS ImmunogenicityQPS Immunogenicity
QPS Immunogenicity
 
QPS Negative Pressure Room
QPS Negative Pressure RoomQPS Negative Pressure Room
QPS Negative Pressure Room
 
QPS Regulated Bioanalysis of Antibody Drug Conjugates
QPS Regulated Bioanalysis of Antibody Drug ConjugatesQPS Regulated Bioanalysis of Antibody Drug Conjugates
QPS Regulated Bioanalysis of Antibody Drug Conjugates
 
QPS Gene Therapy Milestones
QPS Gene Therapy MilestonesQPS Gene Therapy Milestones
QPS Gene Therapy Milestones
 
QPS Bioanalysis Milestones
QPS Bioanalysis MilestonesQPS Bioanalysis Milestones
QPS Bioanalysis Milestones
 
Overcoming Pediatric Trial Challenges
Overcoming Pediatric Trial ChallengesOvercoming Pediatric Trial Challenges
Overcoming Pediatric Trial Challenges
 
Biosimilar Dug Development
Biosimilar Dug DevelopmentBiosimilar Dug Development
Biosimilar Dug Development
 
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS Disorders
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS DisordersThree Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS Disorders
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS Disorders
 
RNAi Therapeutics
RNAi TherapeuticsRNAi Therapeutics
RNAi Therapeutics
 
Pharmacokinetic Studies in Patients
Pharmacokinetic Studies in PatientsPharmacokinetic Studies in Patients
Pharmacokinetic Studies in Patients
 
Seeking Drug Approval via the 505(b)(2) NDA Option
Seeking Drug Approval via the 505(b)(2) NDA OptionSeeking Drug Approval via the 505(b)(2) NDA Option
Seeking Drug Approval via the 505(b)(2) NDA Option
 
Transdermal Delivery Systems
Transdermal Delivery SystemsTransdermal Delivery Systems
Transdermal Delivery Systems
 
Selecting the Location of a Phase I Clinical Trial Site for EU Registration
Selecting the Location of a Phase I Clinical Trial Site for EU RegistrationSelecting the Location of a Phase I Clinical Trial Site for EU Registration
Selecting the Location of a Phase I Clinical Trial Site for EU Registration
 
ICP-MS for Elemental Analysis in Drug Development
ICP-MS for Elemental Analysis in Drug DevelopmentICP-MS for Elemental Analysis in Drug Development
ICP-MS for Elemental Analysis in Drug Development
 
Large Molecule Bioanalysis: LC-MS or ELISA? A Case Study
Large Molecule Bioanalysis: LC-MS or ELISA? A Case StudyLarge Molecule Bioanalysis: LC-MS or ELISA? A Case Study
Large Molecule Bioanalysis: LC-MS or ELISA? A Case Study
 
QPS Human Mass Balance Presentation
QPS Human Mass Balance PresentationQPS Human Mass Balance Presentation
QPS Human Mass Balance Presentation
 
QPS-NL Respiratory Capabilities Presentation
QPS-NL Respiratory Capabilities PresentationQPS-NL Respiratory Capabilities Presentation
QPS-NL Respiratory Capabilities Presentation
 
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...
 

Recently uploaded

THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 

Recently uploaded (20)

THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 

QPS DMPK

  • 1. TIME IS OF THE ESSENCE IN DRUG DEVELOPMENT. CONTACT THE QPS BUSINESS DEVELOPMENT TEAM TODAY! CALL +1 512 350 2827 EMAIL infobd@qps.com DMPK A flexible approach to QPS DMPK PROVIDES A DEDICATED TEAM OF SENIOR SCIENTISTS TO HELP SELECT, design and conduct the appropriate ADME studies for your specific compounds and therapeutic targets. Working with QPS DMPK is a collaborative and consultative endeavor that also incorporates our operational effectiveness and dedication to customer service.
  • 2. Fargo, ND, USA Dermal and Transdermal Research Laboratory (DTRL) Groningen and Leeuwarden, The Netherlands Bioanalysis (BA) Clinical Research Services (CRS) Translational Medicine (TLM) Suzhou and Shanghai, China Bioanalysis (BA) Clinical Research Services (CRS) Miami, FL, USA Clinical Research Services (CRS) Hyderabad, India Bioanalysis (BA) Clinical Research Services (CRS) Taipei, Taiwan Bioanalysis (BA) Clinical Research Services (CRS) Toxicology (TOX) Newark, DE, USA Bioanalysis (BA) Clinical Research Services (CRS) DMPK Translational Medicine (TLM) Global Headquarters for QPS Holdings LLC Graz, Austria Clinical Research Services (CRS) DMPK Histology Services Neuropharmacology Rare Disease Rodent Biobank Springfield, MO, USA Clinical Research Services (CRS) Macro & Micro Autoradiography One of QPS’ main services in DMPK is the combined mass balance, biliary excretion, PK, and QWBA studies. f Increased efficiency by using a single study protocol f Better study oversight with an integrated study report f Elimination of the possibility of radiolabel degrading over an extended period of time between the two studies f Metabolite profiling and identification can be done using the samples from the same study f Micro-autoradiography provides insight into sub-cellular tissue distribution Biotransformation QPS biotransformation studies determine how a molecule may be altered by the action of enzymes. These study types include: f In vitro metabolic stability in hepatic subcellular fractions to determine intrinsic clearance f In vitro comparison of metabolite formation in animal and human hepatic preparations, using non-labeled and radio-labeled test articles f In vivo metabolite profiling, identification and quantification using samples collected from animal PK, mass balance excretion studies, and human AME studies to satisfy Metabolites in Safety Testing (MIST) Protein Binding QPS protein binding studies determine the extent of protein binding in various plasma species and tissues. f Methods: equilibrium dialysis (RED, Harvard device, 96- well HTD), ultrafiltration, and ultracentrifugation f Discovery screening, in vitro protein binding for IND, and ex vivo studies in clinical phases f Experience in compounds with very high binding, stability issues, or non-specific issues Drug-Drug Interaction QPS drug interaction studies determine the potential of a substance to alter cytochrome P450 activity. Studies conducted to assess inhibition and induction potential to support discovery and development of new drug candidates are: f In vitro inhibition characterization in human liver microsomes or hepatocytes to determine reversible or time dependent IC50 f In vitro mechanistic characterization of reversible inhibitory rate constants Ki f Identification of the reversible mechanism of inhibition as competitive, non-competitive or uncompetitive f In vitro mechanistic characterization of time dependent inhibition Kinact and KI f Identification of the mechanism of time dependent inhibition as metabolite mediated via covalent modification or due to tight binding effect of substrate f In vitro characterization of CYP1A2, CYP2B6, and CYP3A4 induction potential in human hepatocytes based on mRNA and/or CYP activity using isoform selective probe substrates QPS is a Global CRO with locations around the world WWW.QPS.COM